Latest filing published 18 Jan 2019 for MediPharm Labs Corp. (formerly POCML 4 Inc.), €2,210.
David John Mayers is a declared insider of MediPharm Labs Corp. (formerly POCML 4 Inc.), with filings sourced from SEDI. The record holds 4 filings, for trades running from 4 October 2018 to 5 November 2018.
The open-market record is one-sided, with 3 purchases worth €38k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2019 to date brings 3 purchases and no sales.
Half of the purchases are above €2,210 and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 18 January 2019, reports an open-market purchase of €2,210 in MediPharm Labs Corp. (formerly POCML 4 Inc.). These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations